KBC Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Hold
5,697
0.01% 596
2026
Q1
$2.74M Hold
5,697
0.01% 605
2025
Q4
$3.2M Hold
5,697
0.01% 535
2025
Q3
$2.93M Hold
5,697
0.01% 530
2025
Q2
$1.79M Buy
5,697
+4,538
+392% +$1.36M ﹤0.01% 603
2025
Q1
$353K Buy
1,159
+6
+0.5% +$2.02K ﹤0.01% 794
2024
Q4
$383K Sell
1,153
-60
-5% -$20.3K ﹤0.01% 862
2024
Q3
$405K Buy
1,213
+63
+5% +$23.9K ﹤0.01% 742
2024
Q2
$474K Buy
1,150
+587
+104% +$232K ﹤0.01% 726
2024
Q1
$228K Buy
563
+57
+11% +$20K ﹤0.01% 822
2023
Q4
$155K Hold
506
﹤0.01% 894
2023
Q3
$123K Buy
+506
New +$129K ﹤0.01% 934
2022
Q2
Sell
-2,862
Closed -$468K 1588
2022
Q1
$468K Hold
2,862
﹤0.01% 833
2021
Q4
$623K Hold
2,862
﹤0.01% 815
2021
Q3
$542K Hold
2,862
﹤0.01% 847
2021
Q2
$506K Hold
2,862
﹤0.01% 876
2021
Q1
$470K Hold
2,862
﹤0.01% 888
2020
Q4
$398K Hold
2,862
﹤0.01% 890
2020
Q3
$320K Sell
2,862
-550
-16% -$63.6K ﹤0.01% 882
2020
Q2
$317K Hold
3,412
﹤0.01% 917
2020
Q1
$250K Sell
3,412
-14,531
-81% -$1.26M ﹤0.01% 986
2019
Q4
$1.51M Hold
17,943
0.01% 761
2019
Q3
$1.51M Hold
17,943
0.01% 733
2019
Q2
$1.17M Sell
17,943
-11,480
-39% -$662K 0.01% 785
2019
Q1
$1.74M Buy
+29,423
New +$1.76M 0.01% 655

Other funds holding MEDP

KBC Group's MEDP Position: Q2 2026 in Review

KBC Group held its Medpace (MEDP) position steady in Q2 2026 at 5,697 shares worth $3.02M. The position accounts for 0.01% of the portfolio, ranked #596.

KBC Group first reported a position in MEDP in Q1 2019 and has held it in 25 quarters since. The position peaked at $3.2M in Q4 2025. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • KBC Group held 5,697 shares of Medpace worth $3.02M as of Q2 2026.
  • KBC Group left its Medpace share count unchanged in Q2 2026.
  • Medpace made up 0.01% of KBC Group's portfolio in Q2 2026, its #596 holding.
  • KBC Group first reported a position in Medpace in Q1 2019 and has held it in 25 quarters since.
  • KBC Group's Medpace position peaked at $3.2M in Q4 2025.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.